@article{4c7086fda0a249af9746593d48523802,
title = "Update on Lipids and Lipoproteins - Reply",
author = "Ference, {Brian A.} and Kastelein, {John J. P.} and Catapano, {Alberico L.}",
note = "Funding Information: Conflict of Interest Disclosures: Dr Ference reported receiving grants and personal fees from Amgen and Merck; grants from Novartis and Esperion Therapeutics; and personal fees from Regeneron, Sanofi, Pfizer, Eli Lilly, Novo Nordisk, Ionis Pharmaceuticals, dalCOR, The Medicines Company, Mylan, CiVi Biopharma, Silence Therapeutics, Krka Pharmaceuticals, the American College of Cardiology, the European Atherosclerosis Society, and the Physicians Academy for Continuing Education. Dr Kastelein reported receiving personal fees from Akcea, AstraZeneca, Daiichi Sankyo, Esperion, The Medicines Company, Novartis, Novo Nordisk, and Regeneron. Dr Catapano reported receiving grants from Sanofi, Regeneron, Amgen, Mylan, Menarini, and Eli Lilly and personal fees from Akcea, Amgen, Sanofi, Esperion, Kowa, Novartis, Ionis Pharmaceuticals, Mylan, Menarini, Merck, Recordati, Regeneron, Daiichi Sankyo, AstraZeneca, Aegerion, Amryt, Sandoz, and Genzyme.",
year = "2021",
month = jan,
day = "26",
doi = "https://doi.org/10.1001/jama.2020.22624",
language = "English",
volume = "325",
pages = "400--401",
journal = "JAMA",
issn = "0098-7484",
publisher = "American Medical Association",
number = "4",
}